Avanafil (3 Offers)

What Is Avanafil?

Avanafil is a prescription medicine belonging to the phosphodiesterase type 5 (PDE5) inhibitor class. In the United States, Avanafil is marketed under the Stendra brand and is indicated for the treatment of erectile dysfunction in adult men.

Avanafil is not a hormone, anabolic steroid or testosterone replacement product. Its pharmacological effect involves the nitric oxide–cyclic GMP pathway involved in penile vascular responses during sexual stimulation.

Avanafil & Stendra

Avanafil identifies the active pharmaceutical ingredient, while Stendra is the recognized U.S. brand name. Generic or manufacturer-specific products may use different branding and packaging while containing Avanafil as the active substance.

When comparing products, check the active ingredient, labeled tablet strength, package quantity and manufacturer rather than relying solely on the brand name or packaging.

How Does Avanafil Work?

Sexual stimulation promotes release of nitric oxide and formation of cyclic guanosine monophosphate (cGMP), which contributes to relaxation of smooth muscle and increased blood flow within erectile tissue.

PDE5 breaks down cGMP. Avanafil inhibits PDE5, allowing cGMP signaling to persist longer when the normal sexual-stimulation pathway has been activated.

For that reason, PDE5 inhibitors do not simply produce an erection independently of sexual stimulation and should not be confused with medicines that directly increase sexual desire.

Avanafil & Erectile Dysfunction

Avanafil is FDA-approved for the treatment of erectile dysfunction (ED) in adult men. Erectile dysfunction refers to persistent difficulty achieving or maintaining an erection sufficient for sexual activity.

ED can have many contributing factors, including cardiovascular disease, diabetes, neurological conditions, medications, psychological factors and hormonal disorders. A PDE5 inhibitor addresses erectile function but does not necessarily identify or correct the underlying cause.

Persistent or newly developing erectile dysfunction can therefore warrant medical evaluation, particularly because it can sometimes coexist with broader cardiovascular or metabolic health concerns.

Avanafil & Onset of Action

One characteristic that distinguishes Avanafil within the PDE5 inhibitor class is its relatively rapid onset option. Current U.S. prescribing information states that certain Avanafil strengths may be taken as early as approximately 15 minutes before sexual activity.

This does not mean that every person will respond at exactly the same time. Individual response can be influenced by the product, health status, other medicines and numerous physiological factors.

The timing information associated with one PDE5 inhibitor should also not automatically be applied to another substance in the same class.

Avanafil vs. Sildenafil

Avanafil and Sildenafil are both PDE5 inhibitors used for erectile dysfunction, but they are separate active pharmaceutical ingredients with different pharmacokinetic characteristics.

Sildenafil is the active ingredient associated with Viagra, while Avanafil is associated with Stendra. Their labeled strengths, timing instructions, interactions and individual responses should not be assumed to be identical.

When comparing them in the catalog, start with the active substance and complete product specification rather than treating all PDE5 inhibitors as interchangeable tablets.

Avanafil vs. Tadalafil

Tadalafil is another PDE5 inhibitor used for erectile dysfunction, but it has substantially different pharmacokinetic characteristics from Avanafil.

Tadalafil is particularly known for its longer duration of pharmacological activity, whereas Avanafil is differentiated partly by its relatively rapid onset. These characteristics describe differences within the same broad drug class rather than indications that one product is universally preferable.

Individual suitability depends on health history, other medicines, desired treatment characteristics and appropriate clinical assessment.

Avanafil vs. Vardenafil

Avanafil and Vardenafil both inhibit PDE5 and can be used in erectile-dysfunction treatment, but they remain different medicines.

Their pharmacokinetics, approved product specifications, interactions and individual tolerability can differ. The presence of several PDE5 inhibitors within the same catalog therefore provides alternatives to compare rather than multiple brand names for one identical substance.

Comparing Avanafil Products

When browsing Avanafil products, useful comparison points include the labeled amount per tablet, total tablet count, manufacturer, current price, warehouse location and published laboratory testing where available.

Products containing Avanafil can differ in tablet strength, package quantity and manufacturer-specific presentation. Reviewing the complete product specification provides a clearer comparison than relying on branding or price alone.

Tablet Strength vs. Package Quantity

The labeled mg-per-tablet strength identifies the amount of Avanafil stated in each tablet. Package quantity separately identifies the total number of tablets supplied.

Two Avanafil products can therefore contain the same active ingredient while differing in tablet strength or package quantity. Check both specifications when comparing available products.

Published Avanafil Lab Reports

Selected Avanafil products may have published laboratory reports that provide an additional reference point when comparing the labeled specification with the measured result reported for a submitted sample.

Where testing is available, review the identified active substance, measured result, testing date and reported batch number. If multiple reports have been published, results from different batches or testing dates can be reviewed individually.

Each laboratory report applies to the submitted sample identified in that analysis. A result from one sample does not independently verify every tablet, package or future production batch.

Avanafil & Nitrates

One of the most important safety considerations with Avanafil is its interaction with nitrate medicines. PDE5 inhibitors can enhance the blood-pressure-lowering effects of nitrates and potentially cause a dangerous drop in blood pressure.

Avanafil should therefore not be combined with organic nitrates used for conditions such as angina. The current U.S. prescribing information lists nitrate use as a contraindication.

This interaction is a class-level consideration shared with other PDE5 inhibitors and is one reason medication history is important when erectile-dysfunction treatment is being considered.

Drug Interactions Matter

Avanafil can interact with other medicines, including drugs that influence blood pressure and medicines that substantially affect its metabolism.

Strong CYP3A4 inhibitors are particularly relevant because they can increase Avanafil exposure. Other cardiovascular medicines and alpha-blockers can also be important when considering the risk of hypotension.

A complete medication list is therefore more useful than evaluating Avanafil solely by tablet strength or product brand.

Avanafil Safety Information

Avanafil is a pharmacologically active prescription medicine. Reported adverse effects include headache, flushing, nasal congestion and other effects associated with PDE5 inhibition.

Because sexual activity can increase cardiovascular workload, underlying cardiovascular status is relevant when erectile-dysfunction treatment is being considered. A PDE5 inhibitor does not make sexual activity medically appropriate for someone in whom it would otherwise be unsafe.

A prolonged erection lasting several hours can cause tissue injury and requires urgent medical assessment. Sudden changes in vision or hearing also require prompt medical attention.

Individual risks depend on cardiovascular health, other medical conditions and concurrent medications. A published laboratory report can provide information about an analyzed product sample but does not establish that taking Avanafil is medically appropriate or safe for an individual.

This category is intended for product identification and comparison and does not provide individualized erectile-dysfunction treatment or dosing guidance.

Priapism Requires Medical Attention

An erection that persists for an unusually long period can represent priapism, a medical emergency because prolonged restriction of normal blood flow can damage erectile tissue.

The U.S. prescribing information for PDE5 inhibitors warns that an erection lasting more than four hours requires immediate medical attention.

This risk should not be interpreted as a sign that a product is unusually strong or effective. It represents a potentially serious adverse event.

Vision & Hearing Warnings

Rare but serious visual and hearing-related events have been reported in association with PDE5 inhibitor use. Sudden loss or significant reduction of vision or hearing warrants prompt medical evaluation.

Existing eye conditions, cardiovascular risk factors and other medical history can influence individual risk and should be considered as part of appropriate clinical assessment.

Avanafil Does Not Increase Sexual Desire

Avanafil helps support the physiological erectile response when sexual stimulation occurs. It should not be confused with a medicine whose primary purpose is to increase libido.

Difficulty with sexual desire and difficulty achieving an erection can have different underlying causes. A PDE5 inhibitor may address erectile function without correcting low libido caused by hormonal, psychological, medication-related or other factors.

Avanafil Does Not Prevent STIs

Avanafil does not prevent pregnancy or protect against sexually transmitted infections. Improving erectile function does not change the need for appropriate safer-sex practices.

PDE5 inhibitor treatment should therefore be considered separately from contraception and prevention of sexually transmitted infections.

Is Avanafil a Testosterone Product?

No. Avanafil is not testosterone and does not belong to the anabolic-androgenic steroid class.

Although low testosterone can contribute to sexual symptoms in some individuals, erectile dysfunction has many possible causes. Avanafil works through PDE5 inhibition and vascular signaling rather than supplying Testosterone.

This distinction is particularly useful in a catalog that includes both hormonal products and sexual-health medicines.

USA Domestic & International Availability

Avanafil products may be available from the USA Domestic Warehouse, the International Warehouse, or both. Available manufacturers, tablet strengths and stock levels can differ between warehouse locations.

For delivery within the United States, USA Domestic shipments typically take 4–5 business days after dispatch, while International Warehouse shipments typically take 15–20 business days after dispatch.

Delivery estimates begin after dispatch and do not include order processing time. Additional delivery, tracking and reship information is available on the Shipping Information page.

Product & Payment Information

Bitcoin and other supported cryptocurrencies are available at checkout. When comparing Avanafil products, review the manufacturer, labeled tablet strength, package quantity, current price, available laboratory reports and warehouse location.

Payment options and warehouse availability do not determine whether Avanafil is medically appropriate for an individual. Where the store's separate crypto discount applies, eligibility depends on the current pricing status of the product.